Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06672666 · ClinicalTrials.gov registry record · Phase 2

Use of CBD in the Treatment of Anxiety

A Phase 2 study of Anxiety and Generalized Anxiety Disorder, sponsored by University of Florida.

Recruiting
Registry status
Phase 2
Development phase
30
Enrollment target
1
Study location

NCT06672666 is a Phase 2 study of Anxiety and Generalized Anxiety Disorder that is actively recruiting participants, run by University of Florida. The registered enrollment target is 30 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06672666, a Phase 2 study of Anxiety and Generalized Anxiety Disorder, is actively recruiting participants, sponsored by University of Florida.

RECRUITING
Registry status
Phase 2
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

This study will examine the doses, safety, and test the preliminary efficacy of hemp-derived CBD product for improving anxiety symptoms and sleep disturbances among individuals with anxiety. A 4-week, randomized, double-blind, placebo-controlled trial will be conducted to determine the safety, tolerability, preliminary efficacy, and acceptability of 50 to 150 mg/day of CBD. The treatment period will consist of a two-week titration period followed by a 2- week maintenance period. In addition, the study seeks to examine whether changes in sleep disturbances precede changes in anxiety symptoms.

Conditions Studied

Anxiety Generalized Anxiety Disorder Sleep Problems

Interventions

  • DRUG Placebo
  • DRUG Hemp Derived Cannabidiol Extract

Study Locations (1)

Florida

  • University of Florida - Gainesville

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2025-01-06
Est. Completion 2026-12-01
Phase Phase 2

Sponsor

University of Florida

1,106 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06672666

The ClinicalTrials.gov registry entry for NCT06672666 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (93% lower). The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Anxiety appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT06672666 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT06672666 about?

NCT06672666 is a clinical study titled "Use of CBD in the Treatment of Anxiety". This study will examine the doses, safety, and test the preliminary efficacy of hemp-derived CBD product for improving anxiety symptoms and sleep disturbances among individuals with anxiety. A 4-week, randomized, double-blind, placebo-controlled trial will be conducted to determine the safety, toler...

What is the current status of trial NCT06672666?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2025-01-06. Estimated completion is 2026-12-01.

What conditions does trial NCT06672666 study?

This clinical trial studies the following conditions: Anxiety, Generalized Anxiety Disorder, Sleep Problems.

What interventions are being tested in trial NCT06672666?

The interventions under investigation include: Placebo (DRUG), Hemp Derived Cannabidiol Extract (DRUG).

Who is sponsoring clinical trial NCT06672666?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06672666 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Anxiety

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Anxiety

All registered trials for this condition

Generalized Anxiety Disorder

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.